drugset / Trial / NCT00647556

Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage

NCT00647556

Phase 3 Completed 30 enrolled Galderma R&D
RandomizedParallel-groupSingle-blindTreatment

Summary

The primary purpose of this study is to compare the efficacy of adapalene (Differin®) gel 0.3% and tretinoin 0.05% emollient cream for the treatment of signs of photodamage, with tolerability assessment as a secondary objective.

Timeline

Start
2008-04
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified 0.3 % Topical
Comparator Tretinoin Small molecule 0.05 % Topical